Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
June 23, 2016

M&As this week: Savara Pharma, Xiangxue Pharmaceuticals

Savara Pharmaceuticals plans to expand its pipeline of orphan respiratory drugs by acquiring Serendex Pharmaceuticals, a provider of inhalation therapies for rare respiratory conditions.

Savara Pharmaceuticals plans to expand its pipeline of orphan respiratory drugs by acquiring Serendex Pharmaceuticals, a provider of inhalation therapies for rare respiratory conditions.

Pursuant to the transaction, Savara Pharma will acquire all of Serendex Pharma’s assets to add up to two new programmes in its pipeline.

Xiangxue Pharmaceuticals has announced that it will acquire a 60% stake in a Guangzhou-based biotechnology company.

Xiangxue Pharmaceuticals plans to acquire the company through stake acquisition and in the form of cash or equity.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU